Trial
NCT05556265
A Study to Evaluate Efficacy and Safety of Deucravacitinib in Participants With Alopecia Areata
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Bristol-Myers Squibb
Collaborators
—
Condition
Alopecia Areata
Intervention
Deucravacitinib
Why stopped
Business objectives have changed
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-05-31